Gelonghui, January 22丨An investor asked Leadman (300289.SZ) on the investor interactive platform, “Are your company's COVID-19 testing products and antigen test kits effective against the currently popular JN.1? Are there technical barriers? What are the applications of biological reagent enzymes?” The company replied that biological reagent enzymes are mainly used in biochemistry, immunity, and molecular diagnosis. The company currently does not produce its own COVID-19 test reagent products.
利德曼(300289.SZ)：目前没有自产的新冠检测试剂产品
Leadman (300289.SZ): There are currently no self-produced COVID-19 test reagent products
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.